Related Experiment Video
Updated: Jun 2, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Statins and oxidative stress]
Florina Filip-Ciubotaru1, Liliana Foia, Carmen Manciuc
1Disciplina Medicina de Familie, Facultatea de Medicină, Universitatea de Medicină si Farmacie Gr.T. Popa Iaşi.
Insights
Statins combat cardiovascular disease by inhibiting cholesterol synthesis and reducing inflammation. Their antioxidant properties further enhance efficacy by scavenging reactive oxygen species and inhibiting oxidized LDL.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiology
Context:
- Statins are primary treatments for cardiovascular disorders, inhibiting HMG-CoA reductase.
- Emerging research highlights statins' anti-inflammatory and antioxidant effects beyond cholesterol reduction.
Purpose:
- To review the literature on statins' antioxidant properties.
- To examine statins' effects on enzymes involved in oxidative stress and antioxidant defense.
Summary:
- Statins inhibit NAD(P)H oxidase, a key source of reactive oxygen species (ROS).
- Statins modulate antioxidant enzymes like SOD, GPx, catalase, and paraoxonase.
- Statins scavenge free radicals and inhibit oxidized low-density lipoprotein (LDL), reducing atherogenic potential.
Impact:
- Statins' antioxidant actions complement their lipid-lowering effects in cardiovascular disease management.
- Understanding these mechanisms can optimize statin therapy for broader cardiovascular protection.
Abstract:
Statins, as inhibitors of the first regulatory enzyme in cholesterol biosynthesis --HMG-CoA reductase--have a special impact in medical practice. Given their therapeutic efficacy, statins are believed to be the strongest class of agents in the treatment of cardiovascular disorders. Moreover, besides decreasing total cholesterol and C-LDL levels, numerous fundamental and clinical researches suggest that statins also have an antiinflammatory effect. Inflammation is closely related to the production of oxygen-derived reactive species (ROS). The antioxidant effects of statins associated with their ability to block the formation and/or action of ROS may add up their therapeutic efficacy. Within this context, the present paper presents data in literature related to the effect of statins on the expression and activity of NAD(P)H oxidase, activity of the enzymes involved in the antioxidative defence (SOD, GPx, catalase, paraoxonase), and their ability to act as free radical scavengers and oxidized-LDL inhibitors. By their antioxidant properties statins may decrease the atherogenic potential of lipoproteins.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Peroxisomes
Peroxisomes
Coronary Artery Disease I: Introduction

